Fueled by a History of Mistreatment, Black Americans Distrust the New COVID-19 Vaccines
When a COVID-19 vaccine becomes widely available to Americans, Brianna Clarke says she won’t be taking it. “I don’t trust the vaccine,” the 22-year-old says. “I think it’s too soon to have a vaccine.” Clarke, who lives in Willingboro, N.J., is among a significant number of Black Americans who are skeptical of the healthcare industry in general and, critically, the COVID-19 vaccines recently developed by pharmaceutical companies Pfizer-BioNTech and Moderna, more specifically. Over the past couple of weeks, the U.S. has averaged in the neighborhood of 200,000 new COVID-19 cases per d...
Source: TIME: Health - December 28, 2020 Category: Consumer Health News Authors: Dezimey Kum Tags: Uncategorized COVID-19 Source Type: news

13 Percent of U.S. Adults Report Serious Psychological Distress During COVID-19
MONDAY, Dec. 14, 2020 -- Serious psychological distress among U.S. adults remained fairly steady between April and July 2020, according to a research letter published online Nov. 23 in the Journal of the American Medical Association. Emma E.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 14, 2020 Category: Pharmaceuticals Source Type: news

Doctors Hail Transparency In FDA And CDC Vaccine Authorizations
The American Medical Association and other U.S. doctor groups hailed the transparency and scientific process used by the U.S. Food and Drug Administration and CDC to clear Pfizer ’s vaccine against Covid-19 over the weekend. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - December 13, 2020 Category: Pharmaceuticals Authors: Bruce Japsen, Senior Contributor Tags: Healthcare /healthcare Innovation /innovation Enterprise Tech /enterprise-tech business pharma Source Type: news

Childhood Lead Exposure Tied to Changes in Adult Brain Structure
WEDNESDAY, Dec. 9, 2020 -- Higher childhood blood lead level is associated with lower structural brain integrity in midlife, according to a study published in the Nov. 17 issue of the Journal of the American Medical Association. Aaron Reuben, from... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 9, 2020 Category: Pharmaceuticals Source Type: news

AMA Pushes for Widespread Telehealth Adoption
WEDNESDAY, Dec. 2, 2020 -- At a Special Meeting of the AMA House of Delegates, the American Medical Association (AMA) adopted a new policy to advocate for widespread adoption of telehealth beyond the COVID-19 pandemic. According to the resolution,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - December 2, 2020 Category: Pharmaceuticals Source Type: news

Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under 18s
Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study from researchers in Portugal and the UK and led by the University of Bristol which evaluated the vaccine ’ s performance in a real-world setting. The findings are published today [1 December] in the Journal of the American Medical Association (JAMA). (Source: University of Bristol news)
Source: University of Bristol news - December 1, 2020 Category: Universities & Medical Training Tags: Health, International, Research; Faculty of Health Sciences, Faculty of Health Sciences, Population Health Sciences, Faculty of Life Sciences, Faculty of Life Sciences, School of Cellular and Molecular Medicine; Press Release Source Type: news

Meningococcus B vaccine prevents disease with 79 per cent effectiveness in under-18s
(University of Bristol) Meningococcus group B, the most prevalent strain of meningococcal infection, is prevented with 79 per cent effectiveness in children and young adults inoculated with the 4CMenB vaccine, also known as Bexsero, according to a new collaborative study from researchers in Portugal and the UK and led by the University of Bristol which evaluated the vaccine's performance in a real-world setting. The findings are published today [1 December] in the Journal of the American Medical Association (JAMA). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 1, 2020 Category: International Medicine & Public Health Source Type: news

Fluvoxamine Linked to Reduction in Clinical Deterioration in COVID-19
WEDNESDAY, Nov. 18, 2020 -- For adult outpatients with COVID-19, fluvoxamine is associated with a reduction in clinical deterioration, according to a study published online Nov. 12 in the Journal of the American Medical Association. Eric J. Lenze,... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 18, 2020 Category: Pharmaceuticals Source Type: news

Major U.S. Medical Groups Urge Trump to Work With Biden on Fighting COVID-19
TUESDAY, Nov. 17, 2020 -- U.S. President Donald Trump needs to work with President-Elect Joe Biden to fight the COVID-19 pandemic as the country grapples with record-breaking numbers of new cases, the American Medical Association, American Nurses... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 17, 2020 Category: Pharmaceuticals Source Type: news

Study: Fish Oil Doesn ’ t Seem To Prevent Heart Problems
This study is consistent with earlier trials. The US Food and Drug Administration approved the fish oil-based drug Vascepa for heart attack and stroke prevention in 2019. Nissen hopes the FDA will take a look at these studies and reconsider that decision. “But it’s hard to get something undone once the genie gets out of the bottle,” he said. An editorial in the journal that accompanies the study written by Dr. Gregory Curfman, assistant professor of medicine at Harvard Medical School, also suggested the FDA should require a postmarketing clinical trial of a high-dose of fish oil, such as Vascepa, vs. corn...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 16, 2020 Category: Consumer Health News Authors: CBS Boston Tags: Boston News Health Syndicated CBSN Boston CNN fish oil Source Type: news

Hydroxychloroquine does not help patients hospitalized with COVID-19: Study
(Vanderbilt University Medical Center) Findings from a national study published today in the Journal of the American Medical Association (JAMA) " do not support " the use of hydroxychloroquine for the treatment of adult patients hospitalized with COVID-19. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 13, 2020 Category: Infectious Diseases Source Type: news

JAMA reports fluvoxamine as potential early treatment for COVID-19
(Allison PR Limited) The COVID-19 Early Treatment Fund (CETF) announced thatJAMA,The Journal of the American Medical Association, published the results of a Washington University School of Medicine in St. Louis double-blind, randomized controlled clinical trial that investigated whether the antidepressant medication fluvoxamine can reduce the risk for respiratory deterioration. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 12, 2020 Category: International Medicine & Public Health Source Type: news

U.S. Sets New Daily COVID-19 Record Amid Election Turmoil
New confirmed cases of the coronavirus in the U.S. have climbed to an all-time high of more than 86,000 per day on average, in a glimpse of the worsening crisis that lies ahead for the winner of the presidential election. Cases and hospitalizations are setting records all around the country just as the holidays and winter approach, demonstrating the challenge that either President Donald Trump or former Vice President Joe Biden will face in the coming months. Daily new confirmed coronavirus cases in the U.S. have surged 45% over the past two weeks, to a record 7-day average of 86,352, according to data compiled by Johns Ho...
Source: TIME: Health - November 5, 2020 Category: Consumer Health News Authors: Lindsey Tanner / AP Tags: Uncategorized COVID-19 overnight wire Source Type: news

AMA: Pandemic Having Negative Financial Impact on Physician Practices
MONDAY, Nov. 2, 2020 -- Medical practices have been economically stressed by the COVID-19 pandemic, with roughly a one-third average drop in revenue, according to a survey released by the American Medical Association (AMA). The AMA asked 3,500... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 2, 2020 Category: Pharmaceuticals Source Type: news

Recommendations Updated for HIV Treatment, Prevention
MONDAY, Oct. 26, 2020 -- In a 2020 guideline from the International Antiviral Society-USA, published online Oct. 14 in the Journal of the American Medical Association, updated recommendations are presented for the treatment and prevention of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 26, 2020 Category: Pharmaceuticals Source Type: news